Clinical trial
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients…
NCT00316888 · ECOG-ACRIN Cancer Research Group, Other · Completed
Key facts
| NCT number | NCT00316888 |
|---|---|
| Title | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer |
| Official title | Phase II Trial of Cetuximab Plus Cisplatin, 5- Fluorouracil and Radiation in Immunocompetent Patients With Anal Carcinoma |
| Lead sponsor | ECOG-ACRIN Cancer Research Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anal Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | cetuximab, cisplatin, fluorouracil, radiotherapy |
| Enrollment | 63 |
| Start date | Feb 28, 2007 |
| Primary completion | Nov 1, 2015 |
| Completion | Aug 17, 2021 |
| First posted | Apr 21, 2006 |
| Last update posted | Jun 29, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: